Tipping the scales: Are females more at risk for obesity- and high-fat diet-induced hypertension and vascular dysfunction?

Lia E. Taylor, Lindsey A. Ramirez, Jacqueline B. Musall, Jennifer C. Sullivan

Research output: Contribution to journalReview article

2 Citations (Scopus)

Abstract

Obesity is a common metabolic disorder that has become a widespread epidemic in several countries. Sex and gender disparities in the prevalence of cardiovascular disease (CVD) have been well documented with premenopausal women having a lower incidence of CVD than age-matched men. However, women are more likely than men to suffer from obesity, which can predispose them to a greater risk of CVD. The mechanisms underlying high-fat diet (HFD)- or obesity-induced hypertension are not well defined, although immune system activation and inflammation have been implicated in several studies. Further, the sex of the subject can have a profound influence on the immune response to hypertensive stimuli. Therefore, the purpose of this review is to examine the effects of sex and gender on the role of the immune system in HFD-induced hypertension and vascular dysfunction. LINKED ARTICLES: This article is part of a themed section on The Importance of Sex Differences in Pharmacology Research. To view the other articles in this section visit http://onlinelibrary.wiley.com/doi/10.1111/bph.v176.21/issuetoc.

Original languageEnglish (US)
Pages (from-to)4226-4242
Number of pages17
JournalBritish Journal of Pharmacology
Volume176
Issue number21
DOIs
StatePublished - Nov 1 2019

Fingerprint

High Fat Diet
Blood Vessels
Cardiovascular Diseases
Obesity
Hypertension
Immune System
Sex Characteristics
Pharmacology
Inflammation
Incidence
Research

ASJC Scopus subject areas

  • Pharmacology

Cite this

Tipping the scales : Are females more at risk for obesity- and high-fat diet-induced hypertension and vascular dysfunction? / Taylor, Lia E.; Ramirez, Lindsey A.; Musall, Jacqueline B.; Sullivan, Jennifer C.

In: British Journal of Pharmacology, Vol. 176, No. 21, 01.11.2019, p. 4226-4242.

Research output: Contribution to journalReview article

@article{66eddde52175446c809b4a412f14f2b9,
title = "Tipping the scales: Are females more at risk for obesity- and high-fat diet-induced hypertension and vascular dysfunction?",
abstract = "Obesity is a common metabolic disorder that has become a widespread epidemic in several countries. Sex and gender disparities in the prevalence of cardiovascular disease (CVD) have been well documented with premenopausal women having a lower incidence of CVD than age-matched men. However, women are more likely than men to suffer from obesity, which can predispose them to a greater risk of CVD. The mechanisms underlying high-fat diet (HFD)- or obesity-induced hypertension are not well defined, although immune system activation and inflammation have been implicated in several studies. Further, the sex of the subject can have a profound influence on the immune response to hypertensive stimuli. Therefore, the purpose of this review is to examine the effects of sex and gender on the role of the immune system in HFD-induced hypertension and vascular dysfunction. LINKED ARTICLES: This article is part of a themed section on The Importance of Sex Differences in Pharmacology Research. To view the other articles in this section visit http://onlinelibrary.wiley.com/doi/10.1111/bph.v176.21/issuetoc.",
author = "Taylor, {Lia E.} and Ramirez, {Lindsey A.} and Musall, {Jacqueline B.} and Sullivan, {Jennifer C.}",
year = "2019",
month = "11",
day = "1",
doi = "10.1111/bph.14783",
language = "English (US)",
volume = "176",
pages = "4226--4242",
journal = "British Journal of Pharmacology",
issn = "0007-1188",
publisher = "Wiley-Blackwell",
number = "21",

}

TY - JOUR

T1 - Tipping the scales

T2 - Are females more at risk for obesity- and high-fat diet-induced hypertension and vascular dysfunction?

AU - Taylor, Lia E.

AU - Ramirez, Lindsey A.

AU - Musall, Jacqueline B.

AU - Sullivan, Jennifer C.

PY - 2019/11/1

Y1 - 2019/11/1

N2 - Obesity is a common metabolic disorder that has become a widespread epidemic in several countries. Sex and gender disparities in the prevalence of cardiovascular disease (CVD) have been well documented with premenopausal women having a lower incidence of CVD than age-matched men. However, women are more likely than men to suffer from obesity, which can predispose them to a greater risk of CVD. The mechanisms underlying high-fat diet (HFD)- or obesity-induced hypertension are not well defined, although immune system activation and inflammation have been implicated in several studies. Further, the sex of the subject can have a profound influence on the immune response to hypertensive stimuli. Therefore, the purpose of this review is to examine the effects of sex and gender on the role of the immune system in HFD-induced hypertension and vascular dysfunction. LINKED ARTICLES: This article is part of a themed section on The Importance of Sex Differences in Pharmacology Research. To view the other articles in this section visit http://onlinelibrary.wiley.com/doi/10.1111/bph.v176.21/issuetoc.

AB - Obesity is a common metabolic disorder that has become a widespread epidemic in several countries. Sex and gender disparities in the prevalence of cardiovascular disease (CVD) have been well documented with premenopausal women having a lower incidence of CVD than age-matched men. However, women are more likely than men to suffer from obesity, which can predispose them to a greater risk of CVD. The mechanisms underlying high-fat diet (HFD)- or obesity-induced hypertension are not well defined, although immune system activation and inflammation have been implicated in several studies. Further, the sex of the subject can have a profound influence on the immune response to hypertensive stimuli. Therefore, the purpose of this review is to examine the effects of sex and gender on the role of the immune system in HFD-induced hypertension and vascular dysfunction. LINKED ARTICLES: This article is part of a themed section on The Importance of Sex Differences in Pharmacology Research. To view the other articles in this section visit http://onlinelibrary.wiley.com/doi/10.1111/bph.v176.21/issuetoc.

UR - http://www.scopus.com/inward/record.url?scp=85070987441&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85070987441&partnerID=8YFLogxK

U2 - 10.1111/bph.14783

DO - 10.1111/bph.14783

M3 - Review article

C2 - 31271650

AN - SCOPUS:85070987441

VL - 176

SP - 4226

EP - 4242

JO - British Journal of Pharmacology

JF - British Journal of Pharmacology

SN - 0007-1188

IS - 21

ER -